ACR 20, 50 and 70 response at 0–18 months for those who were randomised in phase II
| Combination (n = 56) | SASP alone (n = 55) | MTX alone (n = 54) | |
|---|---|---|---|
| ACR, American College of Rheumatology; MTX, methotrexate; SASP, sulfasalazine. | |||
| ACR 20 response | 48 | 32 | 33 |
| ACR 50 response | 25 | 10 | 7 |
| ACR 70 response | 13 | 7 | 4 |